GUCY2D Gene Sequencing

Forms and Documents

Test Details

GUCY2D
  • Confirmation of a clinical diagnosis
  • To differentiate LCA from other forms of retinal dystrophy
  • Recurrence risk assessment
  • Prenatal diagnosis
  • Capillary Sequencing

Ordering

377
4 weeks
2-5 mL Blood - Lavender Top Tube
Oral Rinse (30-40 mL)

Billing

81479x1
No
Yes
  • 743.53 Chorioretinal degeneration, congenital
  • 743.55 Congenital macular changes
  • 362.76 Dystrophies primarily involving the retinal pigment epithelium, Fundus flavimaculatus, Vitelliform dystrophy
  • 362.75 Other dystrophies
  • 743.56 Other retinal changes, congenital
  • 362.74 Pigmentary retinal dystrophy, Retinal dystrophy, albipunctate, Retinitis pigmentosa
* For price inquiries please email zebras@genedx.com

References

  1. Morimura H (1998) Proc Natl Acad Sci 95:3088–3093
  2. Koenekoop (2005) Ophthalmic Genetics 26:175-179
  3. den Hollander AI (2008) Progress in Retinal and Eye Research 27:391-419
  4. Hanein S (2004) Hum Mutat 23:306-317
  5. Booij J (2007) J Med Genet 42:67-75
  6. Stone E (2007) Am J Ophthalmol 144(6):791-811
  7. Koenekoop R (2007) Clin and Experimental Ophthalmology 35:473-485
  8. Browne SJ (2006) Invest Ophthalmol Vis Sci 47(1):34-42
  9. den Hollander AI (2006) Am J Hum Genet 79(3):556-61
  10. Ito S (2004) Invest Ophthalmol Vis Sci 45(5):1480-5
  11. Sohocki (2000) Mol. Genet. Metab. 70, 142–150
  12. Bernal S (2003) J Med Genet 40:e89
  13. den Hollander (1999) Nat Genet 23:217–221
  14. den Hollander (2004) Hum Mutat 24:355-69
  15. den Hollander (2001) Am J Hum Genet 69:198–203